Online inquiry

IVTScrip™ mRNA-Human ARHGAP30, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK21995MR)

This product GTTS-WK21995MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ARHGAP30 protein. This product can be used in FGFR1 High NME5- epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001025598.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 257106
UniProt ID Q7Z6I6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP30, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK21995MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK22341MR IVTScrip™ mRNA-Human ARL4A, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL4A
GTTS-WK3912MR IVTScrip™ mRNA-Human CYR61, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CYR61
GTTS-WK12545MR IVTScrip™ mRNA-Human ADGRL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRL1
GTTS-WK11962MR IVTScrip™ mRNA-Human ADORA3, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADORA3
GTTS-WK9976MR IVTScrip™ mRNA-Human ABI3BP, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ABI3BP
GTTS-WK18555MR IVTScrip™ mRNA-Human ANTXR1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANTXR1
GTTS-WK24971MR IVTScrip™ mRNA-Human ARFGAP3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARFGAP3
GTTS-WK2412MR IVTScrip™ mRNA-Human CYR61, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CYR61
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →